These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34072457)

  • 1. Structural Basis for the Diminished Ligand Binding and Catalytic Ability of Human Fetal-Specific CYP3A7.
    Sevrioukova IF
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of ligand selectivity in CYP3A7 by molecular dynamics simulations.
    Fan JR; Zheng QC; Cui YL; Li WK; Zhang HX
    J Biomol Struct Dyn; 2015; 33(11):2360-7. PubMed ID: 26065334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytochrome P450 3A7 binding four copies of its native substrate dehydroepiandrosterone 3-sulfate.
    Liu J; Kandel SE; Lampe JN; Scott EE
    J Biol Chem; 2023 Aug; 299(8):104993. PubMed ID: 37392852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4.
    Sevrioukova IF; Poulos TL
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):486-491. PubMed ID: 28031486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Based Site of Metabolism (SOM) Prediction of Ligand for CYP3A4 Enzyme: Comparison of Glide XP and Induced Fit Docking (IFD).
    Lokwani DK; Sarkate AP; Karnik KS; Nikalje APG; Seijas JA
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32244772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of template systems for ligand interactions of CYP3A5 and CYP3A7 and their distinctions from CYP3A4 template.
    Yamazoe Y; Tohkin M
    Drug Metab Pharmacokinet; 2021 Jun; 38():100357. PubMed ID: 33866277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of CYP3A4 with caffeine: First insights into multiple substrate binding.
    Sevrioukova IF
    J Biol Chem; 2023 Sep; 299(9):105117. PubMed ID: 37524132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helices F-G are important for the substrate specificities of CYP3A7.
    Torimoto N; Ishii I; Toyama K; Hata M; Tanaka K; Shimomura H; Nakamura H; Ariyoshi N; Ohmori S; Kitada M
    Drug Metab Dispos; 2007 Mar; 35(3):484-92. PubMed ID: 17178770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in assignment of allosteric effects in cytochrome P450-catalyzed substrate oxidations to structural dynamics in the hemoprotein architecture.
    Hlavica P
    J Inorg Biochem; 2017 Feb; 167():100-115. PubMed ID: 27919007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1.
    Rodriguez-Antona C; Axelson M; Otter C; Rane A; Ingelman-Sundberg M
    J Biol Chem; 2005 Aug; 280(31):28324-31. PubMed ID: 15937338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Study of Binding Pockets in Human CYP1A2, CYP3A4, CYP3A5, and CYP3A7 with Aflatoxin B1, a Hepato-Carcinogen, by Molecular Dynamics Simulation & Principal Component Analysis.
    Saba N; Seal A
    Curr Drug Metab; 2022; 23(7):521-537. PubMed ID: 35850656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Investigation of Ligand Binding to the Peripheral Site in CYP3A4: Conformational Dynamics and Inhibitor Discovery.
    Du H; Li J; Cai Y; Zhang H; Liu G; Tang Y; Li W
    J Chem Inf Model; 2017 Mar; 57(3):616-626. PubMed ID: 28221037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Per- and polyfluoroalkyl substances (PFAS) inhibit cytochrome P450 CYP3A7 through direct coordination to the heme iron and water displacement.
    Hvizdak M; Kandel SE; Work HM; Gracey EG; McCullough RL; Lampe JN
    J Inorg Biochem; 2023 Mar; 240():112120. PubMed ID: 36638633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Antifungal Azole Interactions with Adult Cytochrome P450 3A4 versus Neonatal Cytochrome P450 3A7.
    Godamudunage MP; Grech AM; Scott EE
    Drug Metab Dispos; 2018 Sep; 46(9):1329-1337. PubMed ID: 29991575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved cytochrome P450 3A4 molecular models accurately predict the Phe215 requirement for raloxifene dehydrogenation selectivity.
    Moore CD; Shahrokh K; Sontum SF; Cheatham TE; Yost GS
    Biochemistry; 2010 Oct; 49(41):9011-9. PubMed ID: 20812728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the interaction between human P450 3A4 and B. megaterium reductase via engineered loops.
    Castrignanò S; D'Avino S; Di Nardo G; Catucci G; Sadeghi SJ; Gilardi G
    Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):116-125. PubMed ID: 28734977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-embedded substrate recognition by cytochrome P450 3A4.
    Hackett JC
    J Biol Chem; 2018 Mar; 293(11):4037-4046. PubMed ID: 29382727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral ligand-binding site in cytochrome P450 3A4 located with fluorescence resonance energy transfer (FRET).
    Davydov DR; Rumfeldt JA; Sineva EV; Fernando H; Davydova NY; Halpert JR
    J Biol Chem; 2012 Feb; 287(9):6797-809. PubMed ID: 22194603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of catalytic properties of cytochromes P450 3A4 and 3A5 by molecular docking simulation.
    Niwa T; Yasumura M; Murayama N; Yamazaki H
    Drug Metab Lett; 2014; 8(1):43-50. PubMed ID: 24484539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of binding modes of ligands to multiple conformations of CYP3A4.
    Teixeira VH; Ribeiro V; Martel PJ
    Biochim Biophys Acta; 2010 Oct; 1804(10):2036-45. PubMed ID: 20601222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.